Litcius/Paper detail

Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial

Pierre Loap, Delphine Loirat, Frédérique Berger, Francesco Ricci, Anne Vincent‐Salomon, Cyrine Ezzili, Véronique Mosseri, Alain Fourquet, Monia Ezzalfani, Youlia Kirova

2020International Journal of Radiation Oncology*Biology*Physics51 citationsDOI

Topics & Concepts

OlaparibMedicineBreast cancerRadiation therapyOncologyInternal medicinePARP inhibitorTriple-negative breast cancerChemotherapyTaxaneNeoadjuvant therapyPaclitaxelCancerPoly ADP ribose polymeraseGeneChemistryPolymeraseBiochemistryPARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesBRCA gene mutations in cancer
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial | Litcius